Acute myeloid leukemia

Acute myeloid leukemia (AML), also referred to as acute myelogenous leukemia, is a hematological malignancy characterized by the abnormal clonal proliferation of immature myeloid precursors (myeloblasts) or poorly differentiated cells of the hematopoietic system. It primary infiltrates the bone marrow, but the disease can also extend to blood and other tissues.

It is more common in middle-aged and elderly patients, with a median age of diagnosis at 70 years. The M:F rate varies from 1.1 in the 5th decade to about 1.8 in the 8th decade of life 2,3

AML only account to ~20% of all childhood leukaemias, c.f. to acute lymphoblastic leukemia (ALL), which represents ~80% of leukaemias at this age group 2

It has been reported a solid ethnic component in the distribution of most types of AML, with a strong predominance among the white ethnicity group 2,3.   

AML tends to present with vague and nonspecific symptoms such as fatigue and is most commonly revealed on full blood count tests, where anemia, thrombocytopenia, and/or neutropenia are demonstrated 2,4

Described symptoms associated with bone marrow failure include 4:

  • fevers
  • bleeding gums
  • multiple ecchymoses
  • dyspnea on exertion
  • anginal chest pain
  • refractory upper respiratory infection symptoms

Extramedullary leukemic infiltration can lead to organ-involved symptoms such as hepatosplenomegaly, leukemia cutis, lymphadenopathy, gingival hyperplasia, and neurological symptoms 4.

The leukemic myeloblasts can commonly be identified either in peripheral blood smears or bone marrow aspirate. Eventually, there is infiltration of other organs and tissues:

The revised 2016 World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues classifies AML in multiple subtypes 5

Depending on the type of cell lineage involved, AML can be divided into specific morphologic subgroups. 

The leukemic cells are characterized by very little cytoplasm, which holds fine azurophilic granules and Auer bodies or rods. Irregular nuclei and distinct nucleoli are also features of those cells 4.

AML has overall poor prognosis compared to the other main types of leukemia, having ~30% 5-year survival rate 8. This is most evident among elderly patients over 65 years, where up to 70% die within 1 year of diagnosis 8

Share article

Article information

rID: 66761
Section: Gamuts
Synonyms or Alternate Spellings:
  • Acute myeloid leukaemia (AML)
  • Acute granulocytic leukemia
  • Acute myeloblastic leukemia
  • Acute nonlymphocytic leukemia (ANLL)
  • Acute myelogenous leukemia

Support Radiopaedia and see fewer ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.